- Home
- ORMP vs VERU Comparison
ORMP vs VERU Comparison
Compare ORMP & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORMP
- VERU
- Stock Information
- Founded
- ORMP 2002
- VERU 1971
- Country
- ORMP United States
- VERU United States
- Employees
- ORMP N/A
- VERU N/A
- Industry
- ORMP Biotechnology: Pharmaceutical Preparations
- VERU Biotechnology: Pharmaceutical Preparations
- Sector
- ORMP Health Care
- VERU Health Care
- Exchange
- ORMP Nasdaq
- VERU Nasdaq
- Market Cap
- ORMP 90.2M
- VERU 85.5M
- IPO Year
- ORMP N/A
- VERU 1990
- Fundamental
- Price
- ORMP $2.32
- VERU $3.54
- Analyst Decision
- ORMP Hold
- VERU Strong Buy
- Analyst Count
- ORMP 1
- VERU 3
- Target Price
- ORMP N/A
- VERU $33.33
- AVG Volume (30 Days)
- ORMP 96.9K
- VERU 131.5K
- Earning Date
- ORMP 11-06-2025
- VERU 08-12-2025
- Dividend Yield
- ORMP N/A
- VERU N/A
- EPS Growth
- ORMP N/A
- VERU N/A
- EPS
- ORMP N/A
- VERU N/A
- Revenue
- ORMP $2,000,000.00
- VERU $16,886,419.00
- Revenue This Year
- ORMP N/A
- VERU N/A
- Revenue Next Year
- ORMP N/A
- VERU N/A
- P/E Ratio
- ORMP N/A
- VERU N/A
- Revenue Growth
- ORMP N/A
- VERU 337.24
- 52 Week Low
- ORMP $1.82
- VERU $2.64
- 52 Week High
- ORMP $3.09
- VERU $14.20
- Technical
- Relative Strength Index (RSI)
- ORMP 59.64
- VERU 45.20
- Support Level
- ORMP $2.17
- VERU $3.40
- Resistance Level
- ORMP $2.45
- VERU $3.94
- Average True Range (ATR)
- ORMP 0.07
- VERU 0.22
- MACD
- ORMP 0.02
- VERU 0.10
- Stochastic Oscillator
- ORMP 61.76
- VERU 44.44
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.